Isis Pharma (ISIS) -4.8% to $12.41 despite Stifel Nicolaus raising its price target for the...

|By:, SA News Editor

Isis Pharma (ISIS) -4.8% to $12.41 despite Stifel Nicolaus raising its price target for the company to $17 from $11 and maintaining its Buy rating. Stifel made the move after meeting with Isis' management and said investors underestimate the company's pipeline. Shares have been rising since April, although in a fairly volatile fashion.